Neurodegeneration biomarkers for diagnosis of Alzheimer’s and MND
A portfolio of CSF biomarkers corresponding to different stages of the neurodegenerative process aids the diagnosis of Alzheimer’s disease (AD) and motor neuron diseases (MND). The classic AD markers beta amyloid and tau measure aggregates like plaques and tangles. The most reliable measure of amyloid pathology is the ratio of beta amyloid 1-42 to 1-40, […]
